Ganoderma lucidum treatment upregulated the level of Bax and downregulated the level of Bcl-2, resulting in an increase in the ratio of Bax/Bcl-2 in cancer cells (Sohretoglu and Huang, 2018). Here, BAX is linked to cancer.